| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000018241 |
| Receipt No. | R000020946 |
| Official scientific title of the study | Feasibility study of neoadjuvant chemoradiotherapy using Intensity Modulated Radiation Therapy (IMRT) with Docetaxel, CDDP and 5-Fluorouracil (DCF) for cervical esophageal cancer. |
| Date of disclosure of the study information | 2015/07/09 |
| Last modified on | 2018/07/16 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Feasibility study of neoadjuvant chemoradiotherapy using Intensity Modulated Radiation Therapy (IMRT) with Docetaxel, CDDP and 5-Fluorouracil (DCF) for cervical esophageal cancer. | |
| Title of the study (Brief title) | OCD1501 | |
| Region |
|
|
| Condition | ||
| Condition | cervical esophageal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety of preoperative chemoradiotherapy used Intensity Modulated Radiation Therapy:IMR and Docetaxcel/CDDP/5-FU(DCF) for patients with cervical esophageal cancer. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | tbc |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Intensity Modulated Radiation Therapy (IMRT)with Docetaxcel/CDDP/5-FU(DCF) | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Histologically proven cervical esophageal cancer
2) Tumor progress range/cervical esophageal cancer: Ce, CePh 3) Tumor progress range/TNM: T1b,T2,T3,T4 4) Aged over 20 years at the time of registration Performance Status(ECOG):0 or 1 5) Adequate organ function 6) Written IC |
|||
| Key exclusion criteria | 1) History of serious drug hypersensitivity
2) Pregnant, lactating or women of child-bearing potential. Men who want get partner pregnant 3) Active infections 4 4) Serious complications 5) Serious heart disease 6) Peptic ulcers 7) Sensory neuropathy 8) Diarrhea 9) A case with abdominal dropsy and the hydrothorax to need a treatment 10) Brain metastasis 11) Other active malignancies (Nondisease period less than 5 years) 12) Continuous steroid treatment 13) Any other cases who are regarded as inadequate for study enrollment by the investigator 14) Administration contraindication of 5-FU, CDDP, Docetaxel |
|||
| Target sample size | 6 | |||
| Research contact person | |
| Name of lead principal investigator | Makoto Sakai |
| Organization | Gunma University Hospital |
| Division name | Integrative Center of General Surgery |
| Address | 3-39-15 Showa-machi Maebashi Gunma 371-8511 |
| TEL | 027-220-8224 |
| maksakai@gunma-u.ac.jp | |
| Public contact | |
| Name of contact person | Makoto Sakai |
| Organization | Gunma University Hospital |
| Division name | Integrative Center of General Surgery |
| Address | 3-39-15 Showa-machi Maebashi Gunma 371-8511 |
| TEL | 027-220-8224 |
| Homepage URL | |
| maksakai@gunma-u.ac.jp | |
| Sponsor | |
| Institute | Gunma University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | n/a |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020946 |